MarketScreener Homepage > News > Sectors > Healthcare

News : Sectors

ASTRAZENECA PLC

Italian firm developing AstraZeneca's COVID-19 vaccine might go public - CEO

EVERGRANDE HEALTH INDUSTRY GRO.

China Evergrande shares jump on debt reduction progress

DYNAVAX TECHNOLOGIES CORPORATI.

China's Clover says its coronavirus vaccine candidate showed promise in animal test

05:05a	SANOFI : Gets a Neutral rating from Berenberg	MD
05:01a	ROCHE HOLDINGS AG : Berenberg gives a Neutral rating	MD
05:01a	NOVO NORDISK : Gets a Neutral rating from Berenberg	MD
05:01a	GLAXOSMITHKLINE : Berenberg gives a Buy rating	MD
05:01a	ASTRAZENECA : Berenberg gives a Buy rating	MD
05:01a	NOVARTIS AG : Gets a Buy rating from Berenberg	MD
04:26a	SANOFI : Gets a Buy rating from JP Morgan	MD
04:24a	ASTRAZENECA : JP Morgan reaffirms its Buy rating	MD
02:00a	Russian scientist behind COVID-19 vaccine defends 'wartime' roll-out	RE
09/28	PFIZER : FDA Approves Xeljanz to Treat Active Polyarticular Course Juvenile Idiopathic Arthritis	DJ
09/28	Bayer Says European Commission Authorizes XtendFlex Soybeans	DJ
09/28	GLAXOSMITHKLINE : TREASURIES-Yields flat on quiet day ahead of presidential debate	RE
09/28	ASTRAZENECA : Italian firm developing AstraZeneca's COVID-19 vaccine might go public - CEO	RE
09/28	ABBOTT LABORATORIES : Glucose Monitor Gets European Approval	DJ
09/28	ABBVIE : Gets Orphan Drug Designation for Spinal Cord Injury Treatment	DJ

The best opportunities.
All the markets. Each month. In one click.

Discover

09/28	Merck KGaA Appoints New Executive Board Chair, CEO	DJ
09/28	INOVIO PHARMACEUTICALS : potential COVID-19 vaccine trial on partial clinical hold	RE
09/28	MERCK KGAA : DZ Bank reaffirms its Buy rating	MD
09/28	RELIEF THERAPEUTICS : deal with biggest owner lifts cash to $52 mln for COVID-19 trials	RE
09/28	RELIEF THERAPEUTICS : deal with biggest owner lifts cash to $52 mln for COVID-19 trials	RE
09/28	MERCK KGAA : Goldman Sachs reaffirms its Sell rating	MD
09/28	ROCHE : says 59% of SMA patients getting Evrysdi can sit - trial data	RE
09/28	China Evergrande shares jump on debt reduction progress	RE
09/27	China Evergrande New Energy Plans to Issue Up to 1.56 Billion A-Shares in Shanghai Listing	DJ
09/27	GLAXOSMITHKLINE : First U.K. Patient Receives Trial Drug as Treatment for Covid-19	DJ
09/25	JOHNSON & JOHNSON, NIKE, ILLUMINA : Stocks That Defined the Week	DJ
09/25	GLAXOSMITHKLINE : Gets FDA Approval for Blood-Disorder Drug Nucala	DJ
09/25	JOHNSON & JOHNSON : Covid-19 Vaccine Produced Immune Response in Earlier-Stage Study	DJ
09/25	SARTORIUS VORZUEGE : Receives a Buy rating from JP Morgan	MD
09/25	PHILIPS NV : JP Morgan reiterates its Neutral rating	MD
09/25	MORPHOSYS : Goldman Sachs sticks Neutral	MD
09/25	VERTEX PHARMACEUTICALS : Pharma Gets FDA Approval for New Ages for Cystic Fibrosis Treatment	DJ
09/25	GERRESHEIMER AG : JP Morgan reiterates its Neutral rating	MD
09/25	NOVO NORDISK : UBS reiterates its Neutral rating	MD
09/25	DYNAVAX TECHNOLOGIES : China's Clover says its coronavirus vaccine candidate showed promise in animal test	RE
09/25	SARTORIUS VORZUEGE : Gets a Neutral rating from Berenberg	MD
09/25	China Evergrande shares, bonds suffer sell-off on cash-crunch concern	RE
09/25	EXCLUSIVE : AstraZeneca gets partial immunity in low-cost EU vaccine deal	RE
09/25	AstraZeneca gets partial immunity in low-cost EU vaccine deal	RE
09/24	BAYER : resolves more Roundup cases, judge keeps pause on litigation	RE
09/24	BAYER : resolves more Roundup cases, judge keeps pause on litigation	RE
09/24	BECTON DICKINSON AND : in $60 Million Multistate Settlement on Pelvic Mesh Products	DJ
09/24	Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial	RE
09/24	BOSTON SCIENTIFIC : Pulmonx Corp. Sets IPO at 6.67 Million Shares; Sees Pricing at $14-$16 Each	DJ
09/24	STRATEC BIOMEDICAL SYSTEMS AG : Buy rating from Berenberg	MD
09/24	UK shares drop as job support scaled back; AstraZeneca weighs	RE
09/24	ASTRAZENECA : still waiting for FDA go-ahead to resume U.S. trial	RE
09/24	INDIVIOR : targets $70 million savings through job cuts, restructuring	RE
09/24	EU close to concluding preliminary talks with Novavax on COVID vaccine supply - source	RE
09/23	Gilead to pay $97 million to settle U.S. kickback probe	RE
09/23	Brazil's Sao Paulo likely to start COVID-19 immunization in December	RE
09/23	AC IMMUNE : Down 43%; Semorinemab Didn't Meet Endpoint in Early Alzheimer's Disease	DJ
09/23	EU close to concluding preliminary talks with Novavax on COVID vaccine supply - source	RE
09/23	EU close to concluding preliminary talks with Novavax on COVID vaccine supply - source	RE
09/23	ROCHE HOLDINGS AG : Goldman Sachs gives a Buy rating	MD
09/23	Roche Alzheimer's drug fails, joining long list of trial flops	RE
09/23	AC IMMUNE : Down; Semorinemab Didn't Meet Efficacy Endpoint in Early Alzheimer's Disease	DJ
09/23	NOVARTIS AG : Sell rating from Barclays	MD
09/23	BAXTER INTERNATIONAL : Gets FDA OK of Higher-Protein Clinimix, Clinimix E Formulations	DJ
09/23	MORPHOSYS : Gets a Neutral rating from Goldman Sachs	MD
09/23	AC IMMUNE : Semorinemab Didn't Meet Co-Primary Efficacy Endpoint in Early Alzheimer's Disease	DJ
09/23	PFIZER : Gets FDA Priority Review of Xalkori in Rare Pediatric Lymphoma	DJ
09/23	Johnson & Johnson Begins Final-Stage Testing of Covid-19 Vaccine	DJ
09/23	NOVARTIS AG : Goldman Sachs reiterates its Buy rating	MD
09/23	PHILIPS NV : Barclays remains its Buy rating	MD

The best opportunities.
All the markets. Each month. In one click.

Discover

09/23	FRESENIUS SE : Buy rating from Goldman Sachs	MD
09/23	FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reiterates its Buy rating	MD
09/23	GERRESHEIMER AG : Gets a Buy rating from Berenberg	MD
09/23	FRESENIUS SE : Receives a Buy rating from Berenberg	MD
09/23	CARL ZEISS MEDITEC AG : Gets a Neutral rating from Berenberg	MD

1 2 3 4 5 6 7 8 9 10 Next

MOST READ NEWS

1	LVMH MOËT HENNESSY - LOUIS VUITTON S : LVMH MOËT HENNESSY LOUIS VUITTON : countersues Tiffany in bid to drop $..
2	WALMART IN TALKS FOR UP TO $25 BILLION INVESTMENT IN TATA'S 'SUPER APP': Mint
3	TENCENT HOLDINGS LIMITED : U.S. faces ongoing court battles over TikTok, WeChat bans
4	GOLD : Gold steadies ahead of Trump-Biden debate
5	NOVACYT : NOVACYT S.A.: New Contract With UK DHSC for Instrument Platforms and COVID-19 Testing Kits